ProQR Therapeutics (PRQR) Non-cash Items (2014 - 2025)
ProQR Therapeutics (PRQR) posted Non-cash Items of $1169.1 for Q3 2025, up 3.28% sequentially from $1132.0 in Q2 2025, and up 6.45% YoY from $1098.2 in Q3 2024.
ProQR Therapeutics (PRQR) Non-cash Items (2014 - 2025) Analysis & Trends
ProQR Therapeutics has reported Non-cash Items for 12 years, with the latest figure at $1169.1 in Q3 2025.
- Quarterly Non-cash Items rose 6.45% year-over-year to $1169.1 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4451.1 (up 100.05% YoY) and the FY2021 annual result came in at $1183.4, up 3.65% from the prior year.
- Non-cash Items improved to $1169.1 in Q3 2025 per PRQR's latest filing, from $1132.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $48.0 million in Q1 2023 and troughed at -$14.5 million in Q2 2022.
- A 5-year average of -$65852.1 and a median of $1110.3 in 2022 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2023: Non-cash Items sank 1220079.74% in 2022, then jumped 4277152.03% in 2023.
- Over 5 years, Non-cash Items stood at $1144.0 in 2021, then sank by 1257742.63% to -$14.4 million in 2022, then soared by 43.19% to -$8.2 million in 2023, then surged by 100.01% to $1098.2 in 2024, then grew by 6.45% to $1169.1 in 2025.
- According to Business Quant data, Non-cash Items over the past three periods registered $1169.1, $1132.0, and $1051.9 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,169.06 |
| Sep 30, 2025 | 1,169.06 |
| Jun 30, 2025 | 1,131.96 |
| Jun 30, 2025 | 1,131.96 |
| Mar 31, 2025 | 1,051.88 |
| Mar 31, 2025 | 1,051.88 |
| Sep 30, 2024 | 1,098.22 |
| Sep 30, 2024 | 1,098.22 |
| Jun 30, 2024 | 1,076.89 |
| Jun 30, 2024 | 1,076.89 |
| Mar 31, 2024 | 1,086.36 |
| Mar 31, 2024 | 1,086.36 |
| Sep 30, 2023 | -8.17 Mn |
| Sep 30, 2023 | -8.17 Mn |
| Jun 30, 2023 | -12.01 Mn |
| Jun 30, 2023 | -12.01 Mn |
| Mar 31, 2023 | 48.01 Mn |
| Mar 31, 2023 | 48.01 Mn |
| Sep 30, 2022 | -14.39 Mn |
| Sep 30, 2022 | -14.39 Mn |